Canada's main stock index rose on Tuesday, rebounding after Friday's selloff, with investors optimistic about the U.S.

Wedbush analyst Dan Ives raised his price target on Palantir to $200, citing "hyper growth demand" and rapid commercial ...

New trade deadline looms on Thursday, setting stage for last-minute negotiations ...

NEW YORK (AP) — Shares of Palantir Technologies sailed past previous record highs Tuesday after booking its first $1 billion ...

Trump’s tariffs and trade deals continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

Palantir is biggest gainer in the S&P 500 this year. Its latest earnings extend huge gains for the stock, pushing the wealth ...

Palantir's moonshot is paying off with ETF tailwinds. A bunch of thematic and innovation-themed ETFs are bullish, and they're ...

Palantir rose after earnings blew past Wall Street estimates. Shares of Vertex Pharmaceuticals and Hims & Hers plummeted on ...

NEW YORK (AP) — Wall Street is holding steadier on Tuesday following its see-saw ride that bracketed the weekend.